Company Overview of Sangart, Inc.
Sangart, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of oxygen therapeutics. It offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation. The company’s MP4CO, a biopharmaceutical product is used for the treatment of acute painful sickling crises in patients with sickle cell disease. Sangart, Inc. was founded in 1998 and is based in San Diego, California.
6175 Lusk Boulevard
San Diego, CA 92121
Founded in 1998
Key Executives for Sangart, Inc.
Sangart, Inc. Key Developments
Similar Private Companies By Industry
|Nuclea Biotechnologies Inc.||United States|
|Argatroban Royalty Sub, LLC||United States|
|Metabolic Solutions Development Company, LLC||United States|
|A&G Pharmaceutical, Inc.||United States|
|NovaSterilis, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sangart, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.